We deliver health insights
you can count on.
Recognizing the rise of fatty liver disease, we’ve made it our mission to make liver health a new vital sign.
Our novel, portable, handheld solution assesses liver attenuation with ultrasound, and liver stiffness with technology similar to that of MRI elastography, the current non-invasive gold standard. VelacurTM aids in the clinical management of patients with liver disease, with measurements you can count on.
Founded in 2017, Sonic Incytes Medical Corp. is a medical device company headquartered in Vancouver, Canada.
Our proprietary technology aids in the management of patients with liver disease.
We have expertise in ultrasound and medical imaging, medtech, artificial intelligence, machine learning and liver disease.
We’ve cultivated strong partnerships for the benefit
of patients worldwide.